• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者管理:当代真实世界经验。

Managing patients with heart failure: contemporary real-world experience.

机构信息

Department of Research, Saskatchewan Health Authority, Regina, SK, Canada.

College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

出版信息

BMC Res Notes. 2022 Feb 10;15(1):41. doi: 10.1186/s13104-022-05938-z.

DOI:10.1186/s13104-022-05938-z
PMID:35144677
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8832763/
Abstract

OBJECTIVE

Heart failure (HF) is a chronic disease with growing numbers of patients and a significant compromise in quality of life and high mortality. The main purpose of this study was to evaluate the current practices in managing patients with HF among patients admitted to the hospital and discharged with a primary diagnosis of HF and patients managed in the heart function clinic.

RESULTS

This study is a retrospective chart review of patients admitted to the hospital and discharged with a primary diagnosis of HF. A total of 448 patient charts were reviewed, of which 173 patients were in the hospital group and 275 patients in the Clinic group. 278 (62.1%) were men, and 170 (37.9%) were women. The Clinic group of patients were significantly received guideline-directed medical therapy (Beta-blockers, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Diuretics, Mineralocorticoid receptor antagonists-p < 0.001). The Clinic group of patients (17.1%) were significantly less re-hospitalized (p < 0.001) compared to the Hospital group (28%) at 180 days. Physician led multidisciplinary Heart function clinics have better adherence to guideline directed medical therapy and significantly lower rates of re-hospitalization thereby providing cost effective heart failure management with usual care.

摘要

目的

心力衰竭(HF)是一种慢性病,患者数量不断增加,生活质量显著下降,死亡率高。本研究的主要目的是评估因 HF 入院且出院诊断为 HF 的患者和在心脏功能门诊接受管理的患者的 HF 管理现状。

结果

本研究为因 HF 入院且出院诊断为 HF 的患者的回顾性图表审查。共审查了 448 份患者病历,其中 173 份在医院组,275 份在门诊组。278 名(62.1%)为男性,170 名(37.9%)为女性。门诊组患者接受指南指导的药物治疗(β受体阻滞剂、血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂、利尿剂、盐皮质激素受体拮抗剂,p<0.001)的比例显著更高。与医院组(28%)相比,门诊组(17.1%)在 180 天内的再入院率显著更低(p<0.001)。由医生主导的多学科心脏功能门诊在遵循指南指导的药物治疗方面具有更好的依从性,再入院率显著更低,从而在常规护理的基础上提供了具有成本效益的心力衰竭管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fb/8832763/5f463f9526ec/13104_2022_5938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fb/8832763/5f463f9526ec/13104_2022_5938_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6fb/8832763/5f463f9526ec/13104_2022_5938_Fig1_HTML.jpg

相似文献

1
Managing patients with heart failure: contemporary real-world experience.心力衰竭患者管理:当代真实世界经验。
BMC Res Notes. 2022 Feb 10;15(1):41. doi: 10.1186/s13104-022-05938-z.
2
Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure.基于指南的心衰住院后治疗的真实世界分析。
J Am Heart Assoc. 2020 Aug 18;9(16):e015042. doi: 10.1161/JAHA.119.015042. Epub 2020 Aug 4.
3
Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.基于证据的心力衰竭药物治疗的处方模式和 ASIAN-HF 注册研究的结果:一项队列研究。
Lancet Glob Health. 2018 Sep;6(9):e1008-e1018. doi: 10.1016/S2214-109X(18)30306-1.
4
Impact of a Multidisciplinary Heart Failure Postdischarge Management Clinic on Medication Adherence.多学科心力衰竭出院后管理门诊对药物依从性的影响。
Clin Ther. 2017 Jun;39(6):1200-1209. doi: 10.1016/j.clinthera.2017.04.012. Epub 2017 May 22.
5
Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.透析患者因收缩性心力衰竭住院期间指南指导治疗的使用趋势:美国心脏协会 Get With The Guidelines-Heart Failure 项目的研究结果。
JACC Heart Fail. 2016 Aug;4(8):649-61. doi: 10.1016/j.jchf.2016.03.002. Epub 2016 May 11.
6
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.合并糖尿病与射血分数降低心衰(HFrEF)患者的当代治疗模式与临床结局:CHAMP-HF 注册研究。
JACC Heart Fail. 2020 Jun;8(6):469-480. doi: 10.1016/j.jchf.2019.12.015. Epub 2020 May 6.
7
Patient Perceptions and Familiarity With Medical Therapy for Heart Failure.患者对心力衰竭药物治疗的认知与熟悉程度
JAMA Cardiol. 2020 Mar 1;5(3):292-299. doi: 10.1001/jamacardio.2019.4987.
8
Impact of Individual Patient Profiles on Adherence to Guideline Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction: VCOR-HF Study.个体患者特征对射血分数降低的心力衰竭患者遵医嘱治疗的影响:VCOR-HF 研究。
Heart Lung Circ. 2020 Dec;29(12):1782-1789. doi: 10.1016/j.hlc.2020.04.012. Epub 2020 Jun 25.
9
Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study.NT-proBNP 和 GDF-15 辅助的心力衰竭治疗快速优化安全性、耐受性和疗效(STRONG-HF):一项多中心、随机、平行组研究的原理和设计。
Eur J Heart Fail. 2019 Nov;21(11):1459-1467. doi: 10.1002/ejhf.1575. Epub 2019 Aug 19.
10
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.射血分数降低的心力衰竭恶化患者的临床病程。
J Am Coll Cardiol. 2019 Mar 5;73(8):935-944. doi: 10.1016/j.jacc.2018.11.049.

引用本文的文献

1
Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes.2型糖尿病和心力衰竭指南依从性对临床及经济结局影响的系统文献综述
Diabetes Ther. 2025 May;16(5):851-864. doi: 10.1007/s13300-025-01725-8. Epub 2025 Mar 27.
2
Health insurance and clinical outcomes in patients with chronic heart failure in Latin America: an observational study of the Colombian Heart Failure Registry (RECOLFACA).拉丁美洲慢性心力衰竭患者的医疗保险与临床结局:哥伦比亚心力衰竭注册研究(RECOLFACA)的观察性研究。
Heart Vessels. 2024 Dec;39(12):1068-1078. doi: 10.1007/s00380-024-02456-9. Epub 2024 Sep 12.
3

本文引用的文献

1
Impact of multi-disciplinary treatment strategy on systolic heart failure outcome.多学科治疗策略对收缩性心力衰竭预后的影响。
BMC Cardiovasc Disord. 2019 Oct 15;19(1):220. doi: 10.1186/s12872-019-1214-0.
2
Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study.2000-2017 年英国心力衰竭诊断后生存率趋势:基于人群的队列研究。
BMJ. 2019 Feb 13;364:l223. doi: 10.1136/bmj.l223.
3
Multidisciplinary Heart Failure Clinics Are Associated With Lower Heart Failure Hospitalization and Mortality: Systematic Review and Meta-analysis.
Factors Affecting Referral and Patient Access to Heart Function Clinics in Ontario: A Qualitative Study of Stakeholders.
影响安大略省心脏功能诊所转诊及患者就诊的因素:一项利益相关者的定性研究
CJC Open. 2023 Mar 9;5(6):421-428. doi: 10.1016/j.cjco.2023.03.002. eCollection 2023 Jun.
多学科心力衰竭诊所与降低心力衰竭住院率和死亡率相关:系统评价和荟萃分析。
Can J Cardiol. 2017 Oct;33(10):1237-1244. doi: 10.1016/j.cjca.2017.05.011. Epub 2017 May 24.
4
Mineralocorticoid receptor antagonist pattern of use in heart failure with reduced ejection fraction: findings from BIOSTAT-CHF.心力衰竭伴射血分数降低患者中醛固酮受体拮抗剂的使用模式:来自 BIOSTAT-CHF 的发现。
Eur J Heart Fail. 2017 Oct;19(10):1284-1293. doi: 10.1002/ejhf.900. Epub 2017 Jun 5.
5
True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis.安慰剂对照试验中盐皮质激素受体拮抗剂相关高钾血症的真实发生率:一项荟萃分析。
Am Heart J. 2017 Jun;188:99-108. doi: 10.1016/j.ahj.2017.03.011. Epub 2017 Mar 23.
6
Congestive heart failure disease management program: 1-Year population experience from a tertiary center heart failure registry in Saudi Arabia.充血性心力衰竭疾病管理项目:沙特阿拉伯一家三级中心心力衰竭登记处的1年人群经验。
J Saudi Heart Assoc. 2017 Apr;29(2):90-95. doi: 10.1016/j.jsha.2016.07.002. Epub 2016 Jul 21.
7
Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure.高危心力衰竭患者中盐皮质激素受体拮抗剂治疗起始情况的特征分析
Circ Cardiovasc Qual Outcomes. 2017 Jan;10(1). doi: 10.1161/CIRCOUTCOMES.116.002946.
8
Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials.药物依从性干预可改善心力衰竭死亡率和再入院率:对照试验的系统评价和荟萃分析
J Am Heart Assoc. 2016 Jun 17;5(6):e002606. doi: 10.1161/JAHA.115.002606.
9
Barriers to Adoption of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure: A Mixed-Methods Study.心力衰竭患者使用盐皮质激素受体拮抗剂的障碍:一项混合方法研究。
J Am Heart Assoc. 2016 Mar 31;5(3):e002493. doi: 10.1161/JAHA.115.002493.
10
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.盐皮质激素受体拮抗剂(MRAs)在心力衰竭患者中的安全性。
Expert Opin Drug Saf. 2016 May;15(5):659-65. doi: 10.1517/14740338.2016.1163335. Epub 2016 Apr 11.